CONGESTIVE HEART FAILURE (CHF) References

1.            Burgess KR. Central sleep apnoea and heart failure (part II). Respirology 3: 1-11, 1998.

2.            Casillas JM, Gremeaux V, Damak S, Feki A, and Perennou D. Exercise training for patients with cardiovascular disease. Ann Readapt Med Phys 50: 403-418, 386-402, 2007.

3.            Chiariello M, and Perrone-Filardi P. Pathophysiology of heart failure. Miner Electrolyte Metab 25: 6-10, 1999.

4.            Devereux RB, Roman MJ, Paranicas M, Lee ET, Welty TK, Fabsitz RR, Robbins D, Rhoades ER, Rodeheffer RJ, Cowan LD, and Howard BV. A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: the Strong Heart Study. Am Heart J 141: 439-446, 2001.

5.            Dubnov G, Brzezinski A, and Berry EM. Weight control and the management of obesity after menopause: the role of physical activity. Maturitas 44: 89-101, 2003.

6.            Figueroa MS, and Peters JI. Congestive heart failure: Diagnosis, pathophysiology, therapy, and implications for respiratory care. Respir Care 51: 403-412, 2006.

7.            Gabrielsen A, Sorensen VB, Pump B, Galatius S, Videbaek R, Bie P, Warberg J, Christensen NJ, Wroblewski H, Kastrup J, and Norsk P. Cardiovascular and neuroendocrine responses to water immersion in compensated heart failure. Am J Physiol Heart Circ Physiol 279: H1931-1940, 2000.

8.            Gami AS, Hodge DO, Herges RM, Olson EJ, Nykodym J, Kara T, and Somers VK. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 49: 565-571, 2007.

9.            Gehlbach BK, and Geppert E. The pulmonary manifestations of left heart failure. Chest 125: 669-682, 2004.

10.            Grassi G, Seravalle G, Quarti-Trevano F, Scopelliti F, Dell'Oro R, Bolla G, and Mancia G. Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms. Hypertension 49: 535-541, 2007.

11.            Gunnarsson OT, and Judge JO. Exercise at midlife: how and why to prescribe it for sedentary patients. Geriatrics 52: 71-72, 77-80; quiz 81, 1997.

12.       Hall MJ, Xie A, Rutherford R, Ando S, Floras JS, and Bradley TD. Cycle length of periodic breathing in patients with and without heart failure. Am J Respir Crit Care Med 154: 376-381, 1996.

13.            Hollenberg NK. Considerations for management of fluid dynamic issues associated with thiazolidinediones. Am J Med 115 Suppl 8A: 111S-115S, 2003.

14.            Javaheri S. A mechanism of central sleep apnea in patients with heart failure. N Engl J Med 341: 949-954, 1999.

15.            Makaritsis KP, Liakopoulos V, Leivaditis K, Eleftheriadis T, and Stefanidis I. Adaptation of renal function in heart failure. Ren Fail 28: 527-535, 2006.

16.            Manthey J, Dietz R, Opherk D, Osterziel KJ, Leinberger H, and Kubler W. Baroreceptor-mediated release of vasopressin in patients with chronic congestive heart failure and defective sympathetic responsiveness. Am J Cardiol 70: 224-228, 1992.

17.            Naughton M, Benard D, Tam A, Rutherford R, and Bradley TD. Role of hyperventilation in the pathogenesis of central sleep apneas in patients with congestive heart failure. Am Rev Respir Dis 148: 330-338, 1993.

18.            Norman D, and Loredo JS. Obstructive sleep apnea in older adults. Clin Geriatr Med 24: 151-165, ix, 2008.

19.       Patel C, Wyne KL, and McGuire DK. Thiazolidinediones, peripheral oedema and congestive heart failure: what is the evidence? Diab Vasc Dis Res 2: 61-66, 2005.

20.            Piechota G, Malkiewicz J, and Karwat ID. [Obesity as a cause and result of disability]. Przegl Epidemiol 59: 155-161, 2005.

21.            Quaranta AJ, D'Alonzo GE, and Krachman SL. Cheyne-Stokes respiration during sleep in congestive heart failure. Chest 111: 467-473, 1997.

22.            Schrier RW. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. Am J Med 119: S47-53, 2006.

23.            Schweiger TA, and Zdanowicz MM. Vasopressin-receptor antagonists in heart failure. Am J Health Syst Pharm 65: 807-817, 2008.

24.       Sica DA. Sodium and water retention in heart failure and diuretic therapy: basic mechanisms. Cleve Clin J Med 73 Suppl 2: S2-7; discussion S30-33, 2006.

25.            Tkacova R, Niroumand M, Lorenzi-Filho G, and Bradley TD. Overnight shift from obstructive to central apneas in patients with heart failure: role of PCO2 and circulatory delay. Circulation 103: 238-243, 2001.

26.       Topor ZL, Johannson L, Kasprzyk J, and Remmers JE. Dynamic ventilatory response to CO(2) in congestive heart failure patients with and without central sleep apnea. J Appl Physiol 91: 408-416, 2001.

27.            Tremel F, Pepin JL, Veale D, Wuyam B, Siche JP, Mallion JM, and Levy P. High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J 20: 1201-1209, 1999.